Pamir Ozan bought NAGE
June 30, 2026 · Form 4 insider transaction
Pamir Ozan bought 4,255 shares of Niagen Bioscience, Inc. at $2.71 per share, a transaction worth $11.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 8 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,255
Price
$2.71
Total value
$11.5K
InsiderPamir Ozan
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 30, 2026
Filing dateJuly 8, 2026
Shares owned after11,627
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares acquired pursuant to the Issuer's Employee Stock Purchase Plan. The acquisition is exempt under Rule 16b-3(c) and 16b-3(d).